HLA-DRB5 antibody (AA 43-70) (HRP)

Catalog No. ABIN1902455

The Rabbit Polyclonal anti-HLA-DRB5 antibody is suitable to detect HLA-DRB5 in samples from Human. It has been validated for WB, IHC and ELISA.

Quick Overview for HLA-DRB5 antibody (AA 43-70) (HRP) (ABIN1902455)

Target: HLA-DRB5 (Major Histocompatibility Complex, Class II, DR beta 5 (HLA-DRB5))

Reactivity: Human

Host: Rabbit

Clonality: Polyclonal

Conjugate: This HLA-DRB5 antibody is conjugated to HRP

Application: Western Blotting (WB), Immunohistochemistry (IHC), ELISA

Product Details anti-HLA-DRB5 Antibody (HRP)

Binding Specificity: AA 43-70

Specificity: This HLA-DRB5 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 43-70 amino acids from the Central region of human HLA-DRB5.

Purification: Affinity purified

Isotype: IgG

Application Details

Application Notes: Approved: ELISA, IHC, WB

Usage: The applications listed have been tested for the base form of this product. Alternate forms, such as conjugated, azide-free, or ready-to-use, have not been tested.

Comment:

Target Species of Antibody: Human

Restrictions: For Research Use only

Handling

Format: Liquid

Concentration: Lot specific

Buffer: PBS, no preservatives added

Preservative: Without preservative

Handling Advice: Aliquot to avoid repeated freezing and thawing.

Storage: 4 °C,-20 °C

Storage Comment: Short term: store at 4°C. Long term: aliquot and store -20°C for up to 6 months. Avoid freeze-thaw cycles. Protect from light.

Expiry Date: 6 months

Target Details for HLA-DRB5

Target: HLA-DRB5 (Major Histocompatibility Complex, Class II, DR beta 5 (HLA-DRB5))

Alternative Name: HLA-DRB5

Background: Name/Gene ID: HLA-DRB5

Synonyms: HLA-DRB5, DR-9, DR beta-5, Dw2, HLA-DRB, Human leucocyte antigen DRB5, MHC class II antigen DRB1*9, MHC class II HLA beta chain, MHC HLA-DR-beta chain, Leukocyte antigen class II, DR2-beta-2, DR9, MHC class II antigen DRB5

Gene ID: 3127

Pathways: TCR Signaling, Positive Regulation of Peptide Hormone Secretion, Production of Molecular Mediator of Immune Response, Cancer Immune Checkpoints, Human Leukocyte Antigen (HLA) in Adaptive Immune Response